Listened to earnings. Its obvious the drug is being used off label and J&J is done. 30 more country's to add to earnings. Along with Aging population. If trials in other indications are positive then 100 isnt out of reach.
I believe an offer will be made, I just don't think it will be as big as some would like. The market cap is already nearing five billion. Keep in mind this is for half of the US profits and I believe a smaller piece of the international. My guess is an offer comes from Astellas in the 6 billion range, which would be around $80 a share. The price of this stock, much to my joy, has surpassed my expectations already. Perhaps I will be wrong again. I hope so!